Clinical usefulness of biochemical markers of bone turnover in early postmenopausal women: two years longitudinal study;Utilidad clínica de los marcadores bioquímicos de remodelado óseo en la mujer posmenopáusica reciente: estudio longitudinal a 2 años

Medicina Clinica

Volumn 131, Issue 9, 2008, Pages 333-338

  Navarro Casado, Laura ^a   Blázquez Cabrera, José Antonio ^b   del Pino Montes, Javier ^c   Almar Marqués, Enrique ^d   Cháfer Rudilla, Matilde ^a   Mateos Rodríguez, Fernando ^b  

^a Laboratorio de Análisis Clínico   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO DE ALBACETE   (Spain)

^c HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^d Servicio de Epidemiología Dirección Provincial   (Spain)

Author keywords

Biochemical markers; Bone loss; Osteoporosis; Postmenopausal

Indexed keywords

ALKALINE PHOSPHATASE BONE ISOENZYME; AMINO TERMINAL TELOPEPTIDE; BIOCHEMICAL MARKER; CALCIUM; CARBOXY TERMINAL TELOPEPTIDE; DEOXYPYRIDINOLINE; OSTEOCALCIN;

ADULT; ANALYSIS OF VARIANCE; ARTICLE; BIOCHEMISTRY; BONE DENSITOMETRY; BONE DENSITY; BONE MASS; BONE TURNOVER; CALCIUM URINE LEVEL; CORRELATION ANALYSIS; FEMALE; HUMAN; MENOPAUSE; NORMAL HUMAN; OSTEOLYSIS; OSTEOPENIA; OSTEOPOROSIS; POSTMENOPAUSE; PREDICTION AND FORECASTING; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SPINE; STATISTICAL ANALYSIS; STUDENT T TEST; URINALYSIS; BLOOD; BONE; LONGITUDINAL STUDY; METABOLISM; MIDDLE AGED; TIME; URINE;

BONE AND BONES; BONE DENSITY; FEMALE; HUMANS; LONGITUDINAL STUDIES; MIDDLE AGED; POSTMENOPAUSE; TIME FACTORS;

EID: 58249087512     PISSN: 00257753     EISSN: 15788989     Source Type: Journal    
DOI: 10.1157/13125986     Document Type: Article

References (38)

1. NIH Consensus Developmeent Panel on Osteoporosis prevention, diagnosis, and therapy. JAMA. 2001;285:785-95.
2. WHO. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group. World Health Organ Tech Rep Ser 843 (1994) 1-129
3. Baim S., Wilson C., Lewiecki E., Luckey M., Downs R.J., and Lentle B. Precision assessment and radiation safety for dual-energy X-ray absorptiometry: position paper of the International Society for Clinical Densitometry. J Clin Densitom 8 (2005) 371-378
4. Binkley N., Bilezikian J., Kendler D., Leib E., Lewiecki E., Petak S., et al. Official positions of the International Society for Clinical Densitometry and Executive Summary of the 2005 Position Development Conference. J Clin Densitom 9 (2006) 4-14
5. Kanis J.A., Oden A., Johnell O., Johansson H., De Laet C., Brown J., et al. The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int 18 (2007) 1033-1046
6. Garnero P., Sornay-Rendu E., Chapuy M., and Delmas P. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis. J Bone Miner Res 11 (1996) 337-349
7. Christiansen C., Riis B.J., and Rodbro P. Prediction of rapid bone loss in postmenopausal women. Lancet 1 (1987) 1105-1108
8. Dresner-Pollak R., Parker R.A., Poku M., Thompson J., Seibel M.J., and Greenspan S.L. Biochemical markers of bone turnover reflect femoral bone loss in elderly women. Calcif Tissue Int 59 (1996) 328-333
9. Keen R.W., Nguyen T., Sobnack R., Perry L.A., Thompson P.W., and Spector T.D. Can biochemical markers predict bone loss at the hip and spine?: a 4-year prospective study of 141 early postmenopausal women. Osteoporos Int 6 (1996) 399-406
10. Garnero P., Sornay-Rendu E., Duboeuf F., and Delmas P.D. Markers of bone turnover predict postmenopausal forearm bone loss over4 years: the OFELY study. J Bone Miner Res 14 (1999) 1614-1621
11. Looker A.C., Bauer D.C., Chesnut III C.H., Gundberg C.M., Hochberg M.C., Klee G., et al. Clinical use of biochemical markers of bone remodeling: current status and future directions. Osteoporos Int 1 1 (2000) 467-480
12. Matthis C., Weber U., O'Neill T.W., and Raspe H. Health impact associated with vertebral deformities: results from the European Vertebral Osteoporosis Study (EVOS). Osteoporos Int 8 (1998) 364-372
13. De la Piedra C., Traba M., Domínguez Cabrera C., and Sosa Henríquez M. New biochemical markers of bone resorption in the study of postmenopausal osteoporosis. Clin Chim Act 265 (1997) 225-234
14. Seibel M.J., Woitge H., Scheidt-Nave C., LeidigBruckner G., Duncan A., Nicol P., et al. Urinary hydroxypyridinium crosslinks of collagen in population-based screening for overt vertebral osteoporosis: results of a pilot study. J Bone Miner Res 9 (1994) 1433-1440
15. Carter D.R., Bouxsein M.L., and Marcus R. New approaches for interpreting projected bone densitometry data. J Bone Miner Res 7 (1992) 137-145
16. Cvijetic S., and Korsic M. Apparent bone mineral density estimated from DXA in healthy men and women. Osteoporos Int 15 (2004) 295-300
17. Melton I.L., Khosla S., Atkinson E., O'Fallon W., and Riggs B. Relationship of bone Turnover to bone density and fractures. J Bone Miner Res 12 (1997) 1083-1091
18. Siris E., Brenneman S., Barrett-Connor E., Miller P., Sajjan S., Berger M., et al. The effect of age and bone mineral density on the absolute, excess, and relative risk of fracture in postmenopausal women aged 50-99: results from the National Osteoporosis Risk Assessment (NORA). Osteoporos Int 17 (2006) 565-574
19. Fall P.M., Kennedy D., Smith J.A., Seibel M.J., and Raisz L.G. Comparison of serum and urine assays for biochemical markers of bone resorption in postmenopausal women with and without hormone replacement therapy and in men. Osteoporos Int 1 1 (2000) 481-485
20. Ferrer Cañabate J., Tovar Zapata I., Tortosa Oltra J., and Martínez Hernández P. Marcadores bioquímicos de remodelado óseo en el estudio de la masa ósea en la mujer con menopausia reciente sin osteoporosis. Med Clin (Barc) 124 (2005) 241-249
21. Taguchi Y., Gorai I., Zhang M.G., Chaki O., Nakayama M., and Minaguchi H. Differences in bone resorption after menopause in Japanese women with normal or low bone mineral density: quantitation of urinary cross-linked N-telopeptides. Calcif Tissue Int 62 (1998) 395-399
22. Minisola S., Pacitti M.T., Ombricolo E., Costa G., Scarda A., Palombo E., et al. Bone turnover and its relationship with bone mineral density in preand postmenopausal women with or without fractures. Maturitas 29 (1998) 265-270
23. Ravn P., Rix M., Andreassen H., Clemmesen B., Bidstrup M., and Gunnes M. High bone turnover is associated with low bone mass and spinal fracture in postmenopausal women. Calcif Tissue Int 60 (1997) 255-260
24. Schneider D.L., and Barrett-Connor E.L. Urinary N-telopeptide levels discriminate normal, osteopenic, and osteoporotic bone mineral density. Arch Intern Med 157 (1997) 1241-1245
25. Dominguez Cabrera C., Sosa Henriquez M., Traba M.L., Alvarez Villafane E., and De la Piedra C. Biochemical markers of bone formation in the study of postmenopausal osteoporosis. Osteoporos Int 8 (1998) 147-151
26. Iki M., Akiba T., M.atsumoto T., Nishino H., Kagamimori S., and Kagawa Y. Reference database of biochemical markers of bone turnover for the Japanese female population. Japanese Population-based Osteoporosis (JPOS) Study. Osteoporos Int 15 (2004) 981-991
27. Reginster J., Henrotin Y., Christiansen C., GamwellHenriksen E., Bruyere C., and Collette J. Bone resorption in post-menopausal women with normal and low BMD assessed with biochemical markers specific for telopeptide derived degradation products of collagen type I. Calcif Tissue Int 69 (2001) 130-137
28. Seibel M.J. Biochemical Markers of Bone Turnover Part II: Clinical Applications in the Management of Osteoporosis. Clin Biochem Rev 27 (2006) 123-138
29. Estrada M., Ferrer A., Borras A., Benitez D., and Espallargues M. Guía para la indicación de la densitometría ósea en la valoración del riesgo de fractura y el control evolutivo de la osteoporosis (2006,Febrero), Agència d'Avaluació de Tecnología i Recerca Mèdiques. CatSalud. Generalitat de Catalunya, Barcelona
30. New Zealand Guidelines Group (NZGG). Prevention of hip fracture amongst people aged 65 years and over. Full guidelines [monografia en internet]. Wellington (New Zealand); 2003 June [citado 27 mayo 2007]. Disponible en: http://www.nzgg.org. nz/guidelines/0006/Hip_Fracture_Prevention_Full text.pdf
31. Knapen M., Nieuwenhuijzen Kruseman A., Wouters R., and Vermeer C. Correlation of serum osteocalcin fractions with bone mineral density in women during the first 10 years after menopause. Calcif Tissue Int 63 (1998) 375-379
32. Reid I., Ames R., Evans M., Sharpe S., Gamble G., and France J. Determinants of total body and regional bone mineral density in normal postmenopausal women--a key role for fat mass. J Clin Endocrinol Metab 75 (1992) 45-51
33. Meunier P., Jenvrin C., Munoz F., De la Gueronniere V., Garnero P., and Menz M. Consumption of a high calcium mineral water lowers biochemical indices of bone remodeling in postmenopausal women with low calcium intake. Osteoporos Int 16 (2005) 1203-1209
34. Garnero P., Darte C., and Delmas P.D. A model to monitor the efficacy of alendronate treatment in women with osteoporosis using a biochemical marker of bone turnover. Bone 24 (1999) 603-609
35. Rogers A., Hannon R., and Eastell R. Biochemical markers as predictors of rates of bone loss after menopause. J Bone Miner Res 15 (2000) 1398404
36. Chaki O., Yoshikata I., Kikuchi R.M.N., Uchiyama Y., and Hirahara F. The predictive value of biochemical markers of bone turnover for bone mineral density in postmenopausal Japanese women. J Bone Miner Res 15 (2000) 1537-1544
37. Iki M., Morita A., Ikeda Y., Sato Y., Akiba T., Matsumoto T., et al. Biochemical markers of bone turnover predict bone loss in perimenopausal women but not in postmenopausal women-the Japanese Population-based Osteoporosis (JPOS) Cohort Study. Osteoporos Int 17 (2006) 1086-1095
38. Garnero P., Mulleman D., Munoz F., Sornay-Rendu E., and Delmas P. Long-term variability of markers of bone turnover in postmenopausal women and implications for their clinical use: the OFELY study. J Bone Miner Res 18 (2003) 1789-1794